XML 27 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 7 - NIH Grant Funding	6 Months Ended
	Jun. 30, 2012
Grant Funding [Text Block]	7.           NIH Grant Funding In September 2007, the NIH awarded us an Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant to support our HIV/AIDS vaccine program.  We are utilizing this funding to further our HIV/AIDS vaccine development, optimization and production.  We record revenue associated with the grant as the related costs and expenses are incurred and such revenue is reported as a separate line item in our statements of operations.  The project period for the grant covers a five year period which commenced October 2007, with an aggregate award of $20.4 million.  As of June 30, 2012 there is approximately $2.5 million of unused grant funds remaining and available for use; in July 2012, the original project period for use of these funds was extended by one year to August 31, 2013.

X

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References

No definition available.

+ Details

Name:	govx_GrantFundingTextBlock
Namespace Prefix:	govx_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration